vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $270.8M, roughly 1.6× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -15.5%, a 16.3% gap on every dollar of revenue. On growth, EDGEWELL PERSONAL CARE Co posted the faster year-over-year revenue change (-11.6% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-137.5M).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
EPC vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $270.8M |
| Net Profit | $-65.7M | $2.0M |
| Gross Margin | 38.1% | 37.7% |
| Operating Margin | -4.5% | -13.2% |
| Net Margin | -15.5% | 0.7% |
| Revenue YoY | -11.6% | -16.5% |
| Net Profit YoY | -3028.6% | -83.6% |
| EPS (diluted) | $-1.41 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $270.8M | ||
| Q3 25 | $600.5M | — | ||
| Q2 25 | $627.2M | $277.7M | ||
| Q1 25 | $580.7M | $324.5M | ||
| Q4 24 | $415.1M | — | ||
| Q3 24 | $517.6M | — | ||
| Q2 24 | $647.8M | $305.7M | ||
| Q1 24 | $599.4M | — |
| Q4 25 | $-65.7M | $2.0M | ||
| Q3 25 | $-30.6M | — | ||
| Q2 25 | $29.1M | $455.0M | ||
| Q1 25 | $29.0M | $11.9M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $49.0M | $25.8M | ||
| Q1 24 | $36.0M | — |
| Q4 25 | 38.1% | 37.7% | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | 0.1% | ||
| Q1 25 | 44.1% | 48.0% | ||
| Q4 24 | 41.6% | — | ||
| Q3 24 | 41.1% | — | ||
| Q2 24 | 44.3% | 41.1% | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | -13.2% | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | 8.6% | -1.3% | ||
| Q1 25 | 10.1% | -5.0% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 12.8% | -9.0% | ||
| Q1 24 | 11.7% | — |
| Q4 25 | -15.5% | 0.7% | ||
| Q3 25 | -5.1% | — | ||
| Q2 25 | 4.6% | 163.8% | ||
| Q1 25 | 5.0% | 3.7% | ||
| Q4 24 | -0.5% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 7.6% | 8.4% | ||
| Q1 24 | 6.0% | — |
| Q4 25 | $-1.41 | $0.00 | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.62 | $0.52 | ||
| Q1 25 | $0.60 | $0.01 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.18 | — | ||
| Q2 24 | $0.98 | $0.03 | ||
| Q1 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | $1.5B | $93.2M |
| Stockholders' EquityBook value | $1.5B | $1.2B |
| Total Assets | $3.8B | $1.8B |
| Debt / EquityLower = less leverage | 1.03× | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $209.1M | — | ||
| Q2 24 | — | $802.5M | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $93.2M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $93.4M | ||
| Q1 25 | $1.4B | $82.8M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | $82.1M | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $759.9M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | $740.1M | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $3.8B | $1.8B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | $1.8B | ||
| Q1 25 | $3.8B | $1.3B | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.7B | $1.3B | ||
| Q1 24 | $3.8B | — |
| Q4 25 | 1.03× | 0.08× | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | 0.08× | ||
| Q1 25 | 0.95× | 0.11× | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | 0.11× | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $8.2M |
| Free Cash FlowOCF − Capex | $-137.5M | $3.4M |
| FCF MarginFCF / Revenue | -32.5% | 1.2% |
| Capex IntensityCapex / Revenue | 2.7% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $8.2M | ||
| Q3 25 | $74.1M | — | ||
| Q2 25 | $114.8M | $-72.9M | ||
| Q1 25 | $45.1M | $40.3M | ||
| Q4 24 | $-115.6M | — | ||
| Q3 24 | $-388.3M | — | ||
| Q2 24 | $101.2M | $-39.8M | ||
| Q1 24 | $129.0M | — |
| Q4 25 | $-137.5M | $3.4M | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | $99.3M | $-82.2M | ||
| Q1 25 | $28.0M | $32.5M | ||
| Q4 24 | $-132.4M | — | ||
| Q3 24 | $-414.2M | — | ||
| Q2 24 | $88.6M | $-49.9M | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | 1.2% | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 15.8% | -29.6% | ||
| Q1 25 | 4.8% | 10.0% | ||
| Q4 24 | -31.9% | — | ||
| Q3 24 | -80.0% | — | ||
| Q2 24 | 13.7% | -16.3% | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | 1.8% | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.5% | 3.3% | ||
| Q1 25 | 2.9% | 2.4% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 1.9% | 3.3% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | -0.16× | ||
| Q1 25 | 1.56× | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | -44.13× | — | ||
| Q2 24 | 2.07× | -1.54× | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
HCM
Segment breakdown not available.
